Login to stream the interview or access our private podcast.
If you don't have a login, subscribe for free now (HCPs only).
The Baker Lipid Series (Part 5)
Cardiovascular disease remains Australia’s leading cause of death, yet many patients with ASCVD are still not achieving recommended LDL cholesterol targets.
In this practical discussion we discuss why LDL targets matter, what the updated Heart Foundation guidance means for everyday practice, and how GPs can overcome treatment inertia using combination therapy and practical practice tools. The interview also highlights the LipidPlan in a Box toolkit, designed to help practices systematically improve lipid management and patient outcomes.
GP, Platinum Medical Centre, Chermside, Brisbane.
Cardiologist, Adelaide Heart Clinic, South Australia.
GP Edition 169.
Supported by: Produced in June 2026 by Drivetime Radio, with the support of The Baker Heart & Diabetes Institute in collaboration with Novartis.
Tap the share icon
and select 'Add to Home Screen' to add the site to your home screen for quick access!